
Heidelberg Engineering focused on the expected burden glaucoma care could have on healthcare in the next decade at its first International Glaucoma Symposium on February 1.
Held at the University Eye Clinic in Mainz, Germany, the event welcomed delegates from 13 countries who discussed the safe integration of artificial intelligence (AI) into care pathways.
Dr Stephan Schulz, clinical director of glaucoma at Heidelberg Engineering, said: ‘Global experts explored the transformative role of AI in ophthalmology, clinical practice and research. This included optic neuropathies with a focus on glaucoma. The open forums were especially valuable for clinicians to discuss their concerns and the opportunities that AI brings in delivering care to a greater cohort of ageing patients.’
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here